Lys Medical

What we do: Lys Medical is a Belgian medical technology company specializing in the development of ultra-miniaturized advanced endoscopic probes designed to improve lung cancer diagnosis. Their flagship product, Iriscope, enables pulmonologists to reach, visualize, and biopsy hard-to-access peripheral lung nodules with high precision. This innovation significantly accelerates the diagnostic pathway and enhances early cancer detection, aiming to reduce the lung cancer patient journey from months to weeks. Lys Medical operates primarily in the hospital healthcare and pharmaceutical biotech industries.

Where we are located: The company is headquartered at Waterloosesteenweg, 1410 Waterloo, Belgium.

Short history: Founded in 2018 as a spin-off from Université libre de Bruxelles, Lys Medical has developed expertise across the entire medical device lifecycle, including development, manufacturing, certification, clinical validation, and commercialization. This comprehensive approach allows rapid market introduction while maintaining high quality and safety standards.

Organization & culture: Lys Medical is a small, dedicated team of 11 employees who share core values of integrity, innovation, and empathy. The company fosters a collaborative culture where every team member is encouraged to contribute ideas and actively participate in collective success. Lys Medical combines technical expertise with human sensitivity to revolutionize medical care and improve patient outcomes.

Recent developments: Lys Medical continues to work closely with leading medical experts and practitioners to deliver innovative interventional solutions. Their Iriscope product has demonstrated a 93% positive predictive value in diagnosing peripheral lung nodules, supported by recent clinical studies published in 2024. The company remains committed to advancing lung cancer diagnosis and treatment through cutting-edge technology and clinical validation.